Non-Current Assets

Equity Method Investments

Applovin Corporation Equity Method Investments increased by 1367.7% to $287.67M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 322.4%, from $68.10M to $287.67M.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.

Detailed definition

These are investments in entities where the company exercises significant influence but does not have full control. The...

Peer comparison

Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.

Metric ID: equity_method_investments

Historical Data

5 periods
 Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$68.10M$68.10M$47.70M$19.60M$287.67M
QoQ Change+0.0%-30.0%-58.9%>999%
YoY Change+322.4%
Range$19.60M$287.67M
CAGR+322.4%
Avg YoY Growth+322.4%
Median YoY Growth+322.4%

Frequently Asked Questions

What is Applovin Corporation's equity method investments?
Applovin Corporation (APP) reported equity method investments of $287.67M in Q4 2025.
How has Applovin Corporation's equity method investments changed year-over-year?
Applovin Corporation's equity method investments increased by 322.4% year-over-year, from $68.10M to $287.67M.
What does equity method investments mean?
The value of investments in other companies where the firm has significant influence but not total control.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.